Comparison of Intravitreal Ranibizumab, Aflibercept, and Dexamethasone Implant after Bevacizumab Failure in Macular Edema Secondary to Retinal Vascular Occlusions

Publisher： Karger

E-ISSN： 1423-0267|238|1-2|110-118

ISSN： 0030-3755

Source： Ophthalmologica, Vol.238, Iss.1-2, 2017-05, pp. : 110-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population

By  

Ophthalmic Research, Vol. 58, Iss. 1, 2017-03 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema

By  

Ophthalmologica, Vol. 228, Iss. 2, 2012-06 ,pp. : 110-116

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab and/or Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 232, Iss. 4, 2014-11 ,pp. : 216-222

Karger

Access to resources Recommend Favorite

Dexamethasone Implant in Chronic Diabetic Macular Edema Resistant to Intravitreal Ranibizumab Treatment

By  

Ophthalmic Research, Vol. 57, Iss. 3, 2016-12 ,pp. : 161-165

Karger

Access to resources Recommend Favorite

Exploring the Morphological and Functional Retinal Changes after Dexamethasone Intravitreal Implant (Ozurdex®) in Macular Edema due to Retinal Vein Occlusion

By  

Ophthalmic Research, Vol. 51, Iss. 3, 2014-03 ,pp. : 153-160

Karger

Access to resources Recommend Favorite